DK3300482T3 - Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer - Google Patents

Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer Download PDF

Info

Publication number
DK3300482T3
DK3300482T3 DK16797292.6T DK16797292T DK3300482T3 DK 3300482 T3 DK3300482 T3 DK 3300482T3 DK 16797292 T DK16797292 T DK 16797292T DK 3300482 T3 DK3300482 T3 DK 3300482T3
Authority
DK
Denmark
Prior art keywords
prg4
higher order
order aberrations
improve dynamic
dynamic visibility
Prior art date
Application number
DK16797292.6T
Other languages
English (en)
Inventor
Benjamin D Sullivan
Edward R Truitt
Original Assignee
Lubris Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubris Llc filed Critical Lubris Llc
Application granted granted Critical
Publication of DK3300482T3 publication Critical patent/DK3300482T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Prostheses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK16797292.6T 2015-05-19 2016-05-19 Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer DK3300482T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562163753P 2015-05-19 2015-05-19
PCT/US2016/033248 WO2016187414A1 (en) 2015-05-19 2016-05-19 Use of prg4 to improve dynamic visual acuity and higher order aberrations

Publications (1)

Publication Number Publication Date
DK3300482T3 true DK3300482T3 (da) 2021-10-18

Family

ID=57320651

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16797292.6T DK3300482T3 (da) 2015-05-19 2016-05-19 Brug af prg4 til at forbedre dynamisk synsstyrke og højere ordens aberrationer

Country Status (14)

Country Link
US (1) US11666529B2 (da)
EP (1) EP3300482B1 (da)
JP (2) JP7291459B2 (da)
CY (1) CY1124538T1 (da)
DK (1) DK3300482T3 (da)
ES (1) ES2893304T3 (da)
HR (1) HRP20211589T1 (da)
HU (1) HUE056409T2 (da)
LT (1) LT3300482T (da)
MA (1) MA42148A (da)
PL (1) PL3300482T3 (da)
PT (1) PT3300482T (da)
SI (1) SI3300482T1 (da)
WO (1) WO2016187414A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9982027B2 (en) 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
SG11201705636SA (en) 2015-01-26 2017-08-30 Lubris Llc Use of prg4 as an anti-inflammatory agent
KR20210024015A (ko) * 2018-06-21 2021-03-04 루브리스 엘엘씨 상처 치유에 사용하기 위한 루브리신

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
US7415381B2 (en) 2003-01-09 2008-08-19 Rhode Island Hospital, A Lifespan Partner Joint friction sensing
US20060240037A1 (en) 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
US20090155200A1 (en) 2004-04-20 2009-06-18 Jay Gregory D Methods of promoting cartilage healing or cartilage integration
AU2005267012A1 (en) 2004-07-23 2006-02-02 Mucosal Therapeutics Llc Compositions and methods for viscosupplementation
US20080139458A1 (en) 2004-12-03 2008-06-12 Jay Gregory D Methods of Treatment For Injured or Diseased Joints
US20070111327A1 (en) 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
US8144631B2 (en) 2006-12-13 2012-03-27 Cisco Technology, Inc. Interconnecting IP video endpoints with reduced H.320 call setup time
WO2008143816A1 (en) 2007-05-15 2008-11-27 Mucosal Therapeutics Compositions and methods for reducing friction between the surface of tendons or other soft tissues
US20090068247A1 (en) 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
SI2285364T1 (sl) 2008-05-07 2015-03-31 The Regents Of The University Of California Terapevtska regeneracija in obogatitev lubrikacije okularne površine
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
WO2010083239A2 (en) 2009-01-13 2010-07-22 Truitt Edward R Iii Therapeutic modulation of vaginal epithelium boundary lubrication
US9730865B2 (en) 2009-05-22 2017-08-15 Lubris, Llc Application and uses of PRG4 and therapeutic modulation thereof
EP2464375B1 (en) 2009-08-13 2017-06-14 Lubris LLC Prg4 treatment for interstitial cystitis
ES2627103T3 (es) 2010-01-19 2017-07-26 Lubris Llc Composiciones de cuidado bucal y métodos
TWI669554B (zh) 2010-07-30 2019-08-21 瑞士商諾華公司 可易於使用之聚矽氧水凝膠隱形鏡片
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
US20130116186A1 (en) 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
US9982027B2 (en) * 2013-10-22 2018-05-29 Lubris Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
CA2931316C (en) 2013-11-26 2023-03-28 Lubris Llc Compositions and uses thereof for treating or preventing fibrosis
US20180161393A1 (en) 2015-01-26 2018-06-14 Lubris Llc Prg4 for treating gout and its symptoms
SG11201705636SA (en) 2015-01-26 2017-08-30 Lubris Llc Use of prg4 as an anti-inflammatory agent
US20170312335A1 (en) 2015-12-30 2017-11-02 Lubris Llc Topical use of prg4 for treatment of allergy and symptoms of inflammation

Also Published As

Publication number Publication date
JP7291459B2 (ja) 2023-06-15
PT3300482T (pt) 2021-10-15
WO2016187414A1 (en) 2016-11-24
US20180140546A1 (en) 2018-05-24
PL3300482T3 (pl) 2022-01-03
HRP20211589T1 (hr) 2022-01-07
CY1124538T1 (el) 2022-07-22
EP3300482B1 (en) 2021-07-14
JP2021167318A (ja) 2021-10-21
SI3300482T1 (sl) 2021-11-30
ES2893304T3 (es) 2022-02-08
US11666529B2 (en) 2023-06-06
EP3300482A1 (en) 2018-04-04
HUE056409T2 (hu) 2022-02-28
EP3300482A4 (en) 2019-02-13
MA42148A (fr) 2018-04-04
LT3300482T (lt) 2021-10-25
JP2018515534A (ja) 2018-06-14

Similar Documents

Publication Publication Date Title
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3177640T3 (da) Pd-1-midler med høj affinitet og anvendelsesfremgangsmåder
CL2016002416A1 (es) Composiciones estables de yodo no en complejo y métodos de uso
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3145493T3 (da) Fremgangsmåder og sammensætninger vedrørende exosomer
DK3261721T3 (da) Anvendelse af pridopidin til forbedring af hukommelse
KR20180084891A (ko) 구조 조성물 및 방법
DK3274430T3 (da) Mikroalgesammensætninger og deres anvendelser
FR3021533B1 (fr) Composition cosmetique de type gel
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3182962T3 (da) Compositions and uses of amidine derivatives
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
DK3472317T3 (da) Sammensætninger og fremgangsmåder til reduktion af okulær vaskularisation
MA43361A (fr) Composition pour le soin et la protection de cultures
DK3083683T3 (da) Sammensætninger og fremgangsmåder til behandling af fedtvævsansamlinger
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3261609T3 (da) Sammensætninger omfattende ravsyre og akonitsyre
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
CL2017002226A1 (es) Etv2 y usos de los mismos
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf